Why the study?
Excessive cardiac fibroblast activation can drive pathological remodeling, heart failure, and arrhythmias, prompting a review of the mechanisms governing fibroblast-to-myofibroblast transition and cross talk with cardiomyocytes.
Key points are not available for this paper at this time.
Design
Review
This review summarizes the mechanisms of cardiac fibroblast activation, fibroblast-to-myofibroblast transition, and their cross-talk with cardiomyocytes in health and disease.
Cardiac fibroblasts are the primary cell type responsible for deposition of extracellular matrix in the heart, providing support to the contracting myocardium and contributing to a myriad of physiological signaling processes. Despite the importance of fibrosis in processes of wound healing, excessive fibroblast proliferation and activation can lead to pathological remodeling, driving heart failure and the onset of arrhythmias. Our understanding of the mechanisms driving the cardiac fibroblast activation and proliferation is expanding, and evidence for their direct and indirect effects on cardiac myocyte function is accumulating. In this review, we focus on the importance of the fibroblast-to-myofibroblast transition and the cross talk of cardiac fibroblasts with cardiac myocytes. We also consider the current use of models used to explore these questions.
No takes yet. Share an insight, caveat, or question.
Hall et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: